Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.078 SEK
−54.08 M SEK
78.00 K SEK
319.46 M
About XINTELA AB
Sector
Industry
CEO
Evy Lundgren-Åkerlund
Website
Headquarters
Lund
Founded
2009
ISIN
SE0007756903
FIGI
BBG00CGSPCY3
Xintela AB is a biomedical company. It engages in the business of developing medical products in stem cell therapy and targeted cancer therapy based on the cell surface marker integrin a10ß1 which is found on mesenchymal stem cells and on certain aggressive cancer cells. The company was founded by Evy Lundgren-Åkerlund and Rickard Mosell in 2009 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of XINT is 0.324 SEK — it has increased by 3.27% in the past 24 hours. Watch XINTELA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange XINTELA AB stocks are traded under the ticker XINT.
XINT stock has fallen by −3.07% compared to the previous week, the month change is a 0.64% rise, over the last year XINTELA AB has showed a 18.25% increase.
XINT reached its all-time high on Oct 31, 2018 with the price of 5.256 SEK, and its all-time low was 0.200 SEK and was reached on May 24, 2023. View more price dynamics on XINT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
XINT stock is 10.20% volatile and has beta coefficient of 0.57. Track XINTELA AB stock price on the chart and check out the list of the most volatile stocks — is XINTELA AB there?
Today XINTELA AB has the market capitalization of 174.04 M, it has decreased by −3.12% over the last week.
Yes, you can track XINTELA AB financials in yearly and quarterly reports right on TradingView.
XINTELA AB is going to release the next earnings report on Feb 28, 2025. Keep track of upcoming events with our Earnings Calendar.
XINT net income for the last quarter is −7.80 M SEK, while the quarter before that showed −9.99 M SEK of net income which accounts for 21.96% change. Track more XINTELA AB financial stats to get the full picture.
No, XINT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. XINTELA AB EBITDA is −39.88 M SEK, and current EBITDA margin is −70.75 K%. See more stats in XINTELA AB financial statements.
Like other stocks, XINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XINTELA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XINTELA AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XINTELA AB stock shows the sell signal. See more of XINTELA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.